Press release – Collaboration with I-Stem on ASD and DM1

Feb 5, 2019 | Press releases

Ksilink initiates 2 new drug discovery programs on Muscular Dystrophy-1 (DM1) and Autism Spectrum Disorders (ASD) with its strategic partner I-Stem.

Click here to download the press release.

Share This